Cryo-EM structure of MraY in complex with analogue 2
Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-2-2-mer
Ligands
2 x
01:
(2~{S},3~{S})-3-[(2~{S},3~{R},4~{S},5~{R})-5-(aminomethyl)-3,4-bis(oxidanyl)oxolan-2-yl]oxy-2-[[3-[[[(2~{S})-6-azanyl-2-(hexadecanoylamino)hexanoyl]amino]methyl]phenyl]methylamino]-3-[(2~{S},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]propanoic acid
Yamamoto, K. et al., Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target. Nat Commun (2024)
Release Date
2024-06-26
Peptides
Phospho-N-acetylmuramoyl-pentapeptide-transferase: AD MraYAA nanobody: BC
SMTL:PDB
SMTL Chain Id: PDB Chain Id:
A B
D A
B G
C H
Membrane
We predict this structure to be a membrane protein.